Alex Lu is an associate in the litigation department of Goodwin and a member of its Intellectual Property practice. She focuses her practice on patent matters and has litigated patent infringement suits in areas spanning from biotechnology and pharmaceuticals to network technology. Ms. Lu has focused a significant portion of her practice on legal and regulatory issues concerning biosimilars and biologics, and is a founding member and editor of the Big Molecule Watch, an award-winning blog that reports real-time analysis and updates on regulatory issues, litigation, legislation and other news in the developing world of biosimilars (or “big molecules”). Ms. Lu is also a contributing author of Goodwin’s biosimilar resource: Biosimilars: A Guide to Regulatory and Intellectual Property Issues.

Areas of Practice
Domaines D’Expertise





Ms. Lu has extensive experience in all phases of patent litigation from pre-suit patent analysis through trial and appeal, including experience with federal bench and jury trials, summary judgment proceedings, preliminary injunction proceedings, and Federal Circuit appeals.

Ms. Lu also has experience working on arbitrations involving contract disputes in the life sciences space, and inter partes review proceedings before the U.S. Patent Trial and Appeal Board.

Representative matters include:

  • GlaxoSmithKline v. Teva Pharmaceuticals USA, Inc., No. 14-878-LPS (D. Del.) – Represented Teva in patent litigation, including jury trial, concerning Teva’s generic version of Coreg® (carvedilol) tablets.
  • Indivior Inc. v. Dr. Reddy’s Laboratories, S.A., No. 17-7111 (D. N.J.) – Representing Dr. Reddy’s in patent infringement litigation, including a hearing on motion for a preliminary injunction, concerning Dr. Reddy’s applications to market generic versions of Suboxone® (buprenorphine hydrochloride and naloxone hydrochloride) sublingual films.
  • Reckitt Benckiser Pharmaceuticals Inc. v. Dr. Reddy’s Laboratories, S.A., No. 14-1451-RGA (D. Del.) – Represented Dr. Reddy’s in patent infringement litigation, including bench trial, concerning Dr. Reddy’s applications to market generic versions of Suboxone® (buprenorphine hydrochloride and naloxone hydrochloride) sublingual films.  After trial, the court found that Dr. Reddy’s proposed generic product did not infringe any of the asserted patents.
  • Genentech, Inc. v. Celltrion, Inc., No. 18-cv-0574 (D. N.J.) – Represented Celltrion and Teva in patent infringement litigation under the BPCIA, including preparations for hearing on motion for a preliminary injunction, concerning Celltrion’s and Teva’s proposed biosimilar rituximab product.
  • Sophos, Inc. v. RPost Holdings, Inc., No. 13-12856-DJC (D. Mass.) – Represented Sophos in declaratory judgment action regarding Sophos’s network security and email security products.  The court granted Sophos’s motion for summary judgment of invalidity on two independent grounds.
  • Genzyme Corp. v. Dr. Reddy’s Labs., Ltd., No. 13-1506-GMS (D. Del.) – Represented Teva Pharmaceuticals USA, Inc. in patent infringement litigation, including trial, regarding Teva’s application to market a generic version of Genzyme’s stem cell mobilizing agent, Mozobil® (plerixafor).

Ms. Lu is also committed to pro bono work, in which she has focused on matters representing unaccompanied minors seeking asylum and Special Immigrant Juvenile status in immigration and related state court proceedings. Ms. Lu was also an active member of a team that successfully challenged, on First Amendment grounds, city ordinances banning charitable solicitation in public places, and a team that successfully won an immigration case before the Supreme Court concerning the correct interpretation of the stop-time rule for cancellation of removal.

Professional Experience
While in law school, Ms. Lu was a student and student director in the Immigration Legal Services Clinic at Yale Law School, and an editor for the Yale Law Journal. She also worked as a summer intern at the Department of Justice Civil Rights Division, Housing and Civil Enforcement Section.


Ms. Lu was recognized by the American Immigration Lawyers Association as part of the Pereira Litigation Team with the 2019 Jack Wasserman Memorial Award for excellence in litigation in the field of immigration.

In The News









J.D., 2014
Yale Law School
A.B., 2011
Harvard College
(magna cum laude; Phi Beta Kappa; John Harvard Scholar)





U.S. District Court for the District of Massachusetts
U.S. Court of Appeals for the Federal Circuit
U.S. Supreme Court
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique